SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Position Lessened by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. decreased its position in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 4.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,903 shares of the company’s stock after selling 1,154 shares during the period. PNC Financial Services Group Inc. owned 0.49% of SPDR S&P Pharmaceuticals ETF worth $1,060,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Angeles Wealth Management LLC acquired a new position in SPDR S&P Pharmaceuticals ETF during the second quarter worth $40,000. AlphaMark Advisors LLC acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the 2nd quarter valued at about $234,000. Commonwealth Equity Services LLC raised its stake in shares of SPDR S&P Pharmaceuticals ETF by 8.9% in the 2nd quarter. Commonwealth Equity Services LLC now owns 7,364 shares of the company’s stock valued at $293,000 after acquiring an additional 602 shares in the last quarter. CX Institutional lifted its holdings in SPDR S&P Pharmaceuticals ETF by 117.2% in the 2nd quarter. CX Institutional now owns 9,711 shares of the company’s stock worth $386,000 after purchasing an additional 5,240 shares during the last quarter. Finally, U.S. Capital Wealth Advisors LLC lifted its holdings in SPDR S&P Pharmaceuticals ETF by 44.1% in the 2nd quarter. U.S. Capital Wealth Advisors LLC now owns 18,066 shares of the company’s stock worth $719,000 after purchasing an additional 5,531 shares during the last quarter.

SPDR S&P Pharmaceuticals ETF Stock Up 1.1 %

Shares of XPH stock opened at $46.28 on Thursday. SPDR S&P Pharmaceuticals ETF has a 12 month low of $36.49 and a 12 month high of $48.76. The company has a market cap of $224.46 million, a PE ratio of 14.39 and a beta of 0.87. The business’s 50 day moving average is $45.67 and its two-hundred day moving average is $43.15.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.